Schaap NP

ORCID: 0000-0001-7696-4752 · 1 paper in corpus
2020
Oncoimmunology ·doi:10.1080/2162402x.2020.1843247

Advanced ovarian cancer (OC) patients have a poor 5-year survival of only 28%, emphasizing the medical need for improved therapies. Adjuvant immunotherapy could be an attractive approach since OC is an immunogenic disease and the presence o…